Illinois General Assembly - Full Text of HB0286
Illinois General Assembly

Previous General Assemblies

Full Text of HB0286  97th General Assembly

HB0286ham001 97TH GENERAL ASSEMBLY

Rep. Mary E. Flowers

Filed: 3/16/2011

 

 


 

 


 
09700HB0286ham001LRB097 06663 KTG 53120 a

1
AMENDMENT TO HOUSE BILL 286

2    AMENDMENT NO. ______. Amend House Bill 286 by replacing
3everything after the enacting clause with the following:
 
4    "Section 1. Short title. This Act may be cited as the
5Administration of Psychotropic Medications to Children Act.
 
6    Section 2. Legislative Findings. The General Assembly
7recognizes that:
8    (a) Mental illnesses among children and adolescents can be
9severely debilitating and, if untreated, can have a negative
10effect on their education, their families and communities, and
11their future lives as productive citizens of Illinois.
12    (b) Psychotropic medications, when used carefully and
13appropriately, can be safe and effective treatments for
14children with serious mental illnesses.
15    (c) Psychotropic medications, like most other medications,
16may pose serious risks and side effects, particularly if their

 

 

09700HB0286ham001- 2 -LRB097 06663 KTG 53120 a

1use is not carefully monitored.
2    (d) Under Illinois law, minors cannot give consent to
3medical treatment, including psychotropic medications.
4    (e) Under Illinois law, in the absence of an emergency,
5medical treatment, including the administration of
6psychotropic medications, may only be provided to a minor with
7the consent of a parent, a guardian, or some other person
8authorized by law to give consent.
9    (f) The Department of Children and Family Services has
10responsibility for providing informed consent for medical
11treatment, including the administration of psychotropic
12medications, for thousands of children and adolescents.
13    (g) The health, safety, and well-being of children and
14adolescents who are the legal responsibility of the Department
15depend on the existence and enforcement of appropriate
16standards and procedures through which the Department may
17determine when the use of psychotropic medications is
18appropriate for these children and adolescents.
 
19    Section 5. Administration of psychotropic medications. On
20or before October 1, 2011, the Department of Children and
21Family Services shall promulgate final rules, amending its
22current rules establishing and maintaining standards and
23procedures to govern the administration of psychotropic
24medications. Such amendments to its rules shall include, but
25are not limited to, the following:

 

 

09700HB0286ham001- 3 -LRB097 06663 KTG 53120 a

1    (a) The role of the Department in the administration of
2psychotropic medications to youth for whom it is legally
3responsible and who are in facilities operated by the Illinois
4Department of Corrections or the Illinois Department of
5Juvenile Justice.
6    (b) Provisions regarding the administration of
7psychotropic medications for youth for whom the Department is
8legally responsible and who are in residential facilities,
9group homes, transitional living programs, or foster homes
10where the youth is under the age of 18 or where the youth is 18
11or older and has provided the Department with appropriate
12consent.
13    (c) Provisions regarding the administration of
14psychotropic medications for youth for whom the Department is
15legally responsible and who are in psychiatric hospitals.
16    (d) Provisions concerning the emergency use of
17psychotropic medications, including appropriate and timely
18reporting.
19    (e) Provisions prohibiting the administration of
20psychotropic medications to persons for whom the Department is
21legally responsible as punishment for bad behavior, for the
22convenience of staff or caregivers, or as a substitute for
23adequate mental health care or other services.
24    (f) The creation of a committee to develop, post on a
25website, and periodically review materials listing which
26psychotropic medications are approved for use with youth for

 

 

09700HB0286ham001- 4 -LRB097 06663 KTG 53120 a

1whom the Department has legal responsibility. The materials
2shall include guidelines for the use of psychotropic
3medications and may include the acceptable range of dosages,
4contraindications, and time limits, if any, and such other
5topics necessary to ensure the safe and appropriate use of
6psychotropic medications.
7    (g) Provisions regarding the appointment, qualifications,
8and training of employees of the Department who are authorized
9to consent to the administration of psychotropic medications to
10youth for whom the Department has legal responsibility,
11including the scope of the authority of such persons.
12    (h) Provisions regarding training and materials for
13parents, foster parents, and relative caretakers concerning
14the rules governing the use of psychotropic medications with
15youth for whom the Department has legal responsibility.
16    (i) With respect to any youth under the age of 18 for whom
17the Department has legal responsibility and who does not assent
18to the administration of recommended psychotropic medication,
19provisions providing standards and procedures for reviewing
20the youth's concerns. With respect to any youth over the age of
2118 for whom the Department has legal responsibility and who
22does not consent to the administration of recommended
23psychotropic medication, provisions providing standards and
24procedures for reviewing the youth's concerns upon the youth's
25request and with the youth's consent. Standards and procedures
26developed under this subsection shall not be inconsistent with

 

 

09700HB0286ham001- 5 -LRB097 06663 KTG 53120 a

1the Mental Health and Developmental Disabilities Code.
2    (j) Provisions ensuring that, subject to all relevant
3confidentiality laws, service plans for youth for whom the
4Department has legal responsibility include the following
5information:
6        (1) Identification by name and dosage of the
7    psychotropic medication known by the Department to have
8    been administered to the youth since the last service plan.
9        (2) The benefits of the psychotropic medication.
10        (3) The negative side effects of the psychotropic
11    medication.
 
12    Section 10. Failure to comply with Department rules. The
13Department must establish and maintain rules designed to ensure
14compliance with any rules promulgated pursuant to Section 5 of
15this Act. Such rules shall include, but are not limited to, the
16following:
17    (a) Standards and procedures for notifying physicians,
18residential treatment facilities, and psychiatric hospitals
19when they have violated any rule enacted or maintained pursuant
20to Section 5 of this Act.
21    (b) Standards and procedures for issuing written warnings
22to physicians, residential treatment facilities, and
23psychiatric hospitals when they have violated any rule enacted
24or maintained pursuant to Section 5 of this Act.
25    (c) Standards and procedures for notifying the Department

 

 

09700HB0286ham001- 6 -LRB097 06663 KTG 53120 a

1of Financial and Professional Regulation when a physician has
2repeatedly violated any rule enacted or maintained pursuant to
3Section 5 of this Act after having received a written warning
4on one or more occasions. This subsection is not intended to
5limit the Department's authority to make a report to the
6Department of Financial and Professional Regulation when a
7physician has violated a rule and has not received a written
8warning when the Department determines it is in the minor's and
9society's interest to make the report.
10    (d) Standards and procedures for notifying the Department
11of Public Health when any facility licensed by that Department
12has repeatedly violated any rule enacted or maintained pursuant
13to Section 5 of this Act after having received a written
14warning on one or more occasions. This subsection is not
15intended to limit the Department's authority to make a report
16to the Department of Public Health when a facility has violated
17a rule and has not received a written warning when the
18Department determines it is in the minor's and society's
19interest to make the report.
20    (e) Standards and procedures for notifying the guardian ad
21litem appointed pursuant to Section 2-17 of the Juvenile Court
22Act of 1987, of a ward who has been administered psychotropic
23medication in violation of any rule enacted or maintained
24pursuant to Section 5 of this Act, where the guardian ad litem
25has requested notification and provides the Department with
26documentation verifying that pursuant to the Mental Health and

 

 

09700HB0286ham001- 7 -LRB097 06663 KTG 53120 a

1Developmental Disabilities Confidentiality Act, the court has
2entered an order granting the guardian ad litem authority to
3receive and review this information.
4    (f) Standards and procedures for notifying the
5Department's licensing division when a residential facility or
6group home licensed by the Department has repeatedly violated
7any rule enacted or maintained pursuant to Section 5 of this
8Act.
 
9    Section 15. Annual report.
10    (a) No later than December 31 of each year, the Department
11shall prepare and submit an annual report, covering the
12previous fiscal year, to the General Assembly concerning the
13administration of psychotropic medication to persons for whom
14it is legally responsible. This report shall include, but is
15not limited to, the following:
16        (1) The number of violations of any rule enacted
17    pursuant to Section 5 of this Act.
18        (2) The number of warnings issued pursuant to
19    subsection (b) of Section 10 of this Act.
20        (3) The number of physicians who have been issued
21    warnings pursuant to subsection (b) of Section 10 of this
22    Act.
23        (4) The number of physicians who have been reported to
24    the Department of Financial and Professional Regulation
25    pursuant to subsection (c) of Section 10 of this Act, and,

 

 

09700HB0286ham001- 8 -LRB097 06663 KTG 53120 a

1    if available, the results of such reports.
2        (5) The number of facilities that have been reported to
3    the Department of Public Health pursuant to subsection (d)
4    of Section 10 of this Act and, if available, the results of
5    such reports.
6        (6) The number of Department-licensed facilities that
7    have been the subject of licensing complaints pursuant to
8    subsection (f) of Section 10 of this Act, and if available,
9    the results of the complaint investigations.
10        (7) Any recommendations for legislative changes or
11    amendments to any of its rules or procedures established or
12    maintained in compliance with this Act.
13    (b) The requirement for reporting to the General Assembly
14shall be satisfied by filing copies of the report with the
15Speaker, the Minority Leader, and the Clerk of the House of
16Representatives, the President, the Minority Leader, and the
17Secretary of the Senate, and the Legislative Research Unit, as
18required by Section 3.1 of the General Assembly Organization
19Act and by filing additional copies with the State Government
20Report Distribution Center for the General Assembly as required
21under paragraph (t) of Section 7 of the State Library Act.
 
22    Section 99. Effective date. This Act takes effect upon
23becoming law.".